Jianghong An

4.1k total citations
20 papers, 1.1k citations indexed

About

Jianghong An is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Jianghong An has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Computational Theory and Mathematics and 3 papers in Oncology. Recurrent topics in Jianghong An's work include Computational Drug Discovery Methods (7 papers), Protein Structure and Dynamics (4 papers) and Genomics and Rare Diseases (2 papers). Jianghong An is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Protein Structure and Dynamics (4 papers) and Genomics and Rare Diseases (2 papers). Jianghong An collaborates with scholars based in Canada, United States and China. Jianghong An's co-authors include Ruben Abagyan, Maxim Totrov, Steven J.M. Jones, Yvonne Y. Li, Marco A. Marra, Andrew J. Mungall, William T. Gibson, Kym M. Boycott, Riyana Babul‐Hirji and Patrice Eydoux and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Bioinformatics.

In The Last Decade

Jianghong An

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianghong An Canada 13 865 323 159 104 101 20 1.1k
Mark Agostino Australia 16 778 0.9× 167 0.5× 80 0.5× 110 1.1× 40 0.4× 41 1.1k
Christopher A. Pargellis United States 13 859 1.0× 151 0.5× 194 1.2× 67 0.6× 70 0.7× 17 1.1k
Roberta Bosotti Italy 13 1.0k 1.2× 420 1.3× 66 0.4× 157 1.5× 30 0.3× 28 1.4k
Brian B. Haines United States 17 948 1.1× 196 0.6× 222 1.4× 188 1.8× 47 0.5× 39 1.4k
E. Salah United Kingdom 19 1.0k 1.2× 153 0.5× 68 0.4× 149 1.4× 78 0.8× 47 1.4k
Anna Rodina United States 20 1.6k 1.9× 368 1.1× 52 0.3× 120 1.2× 122 1.2× 32 2.1k
Till Maurer Germany 17 1.2k 1.3× 126 0.4× 139 0.9× 62 0.6× 148 1.5× 32 1.5k
Kush Dalal Canada 18 748 0.9× 106 0.3× 344 2.2× 119 1.1× 34 0.3× 40 1.2k
Ambuj Kumar India 16 627 0.7× 101 0.3× 108 0.7× 85 0.8× 35 0.3× 37 840
Wang‐Qing Liu France 20 805 0.9× 114 0.4× 76 0.5× 95 0.9× 50 0.5× 54 1.2k

Countries citing papers authored by Jianghong An

Since Specialization
Citations

This map shows the geographic impact of Jianghong An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghong An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghong An more than expected).

Fields of papers citing papers by Jianghong An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianghong An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghong An. The network helps show where Jianghong An may publish in the future.

Co-authorship network of co-authors of Jianghong An

This figure shows the co-authorship network connecting the top 25 collaborators of Jianghong An. A scholar is included among the top collaborators of Jianghong An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianghong An. Jianghong An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wee, Kathleen, Laura Williamson, Emma Titmuss, et al.. (2022). Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis. Melanoma Research. 32(4). 278–285. 2 indexed citations
2.
Gill, Harinder, Margaret L. McKinnon, Bertrand Isidor, et al.. (2020). SETD1B-associated neurodevelopmental disorder. Journal of Medical Genetics. 58(3). 196–204. 19 indexed citations
3.
Qian, Shen, Jianghong An, Furong Qi, et al.. (2020). Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis. Annals of Translational Medicine. 8(14). 881–881. 6 indexed citations
4.
Hanley, Ronan P., et al.. (2015). Salicylates are interference compounds in TR-FRET assays. Bioorganic & Medicinal Chemistry Letters. 26(3). 973–977. 12 indexed citations
5.
Dean, Richard A., Jianghong An, Kunho Choi, et al.. (2014). Identification of a Putative Tdp1 Inhibitor (CD00509) by in Vitro and Cell-Based Assays. SLAS DISCOVERY. 19(10). 1372–1382. 41 indexed citations
6.
Bergqvist, Peter, Alireza Heravi‐Moussavi, Edie Dullaghan, et al.. (2014). A Pan-Cancer Analysis of Alternative Splicing Events Reveals Novel Tumor-Associated Splice Variants of Matriptase. Cancer Informatics. 13. CIN.S19435–CIN.S19435. 10 indexed citations
7.
Cetinbas, Naniye Mallı, Cristina E. Tognon, Gabriel Leprivier, et al.. (2013). Mutation of the Salt Bridge-forming Residues in the ETV6-SAM Domain Interface Blocks ETV6-NTRK3-induced Cellular Transformation. Journal of Biological Chemistry. 288(39). 27940–27950. 11 indexed citations
8.
Trinh, Diane L., David W. Scott, Ryan D. Morin, et al.. (2013). Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood. 121(18). 3666–3674. 104 indexed citations
9.
10.
Gibson, William T., Rebecca L. Hood, Shing H. Zhan, et al.. (2011). Mutations in EZH2 Cause Weaver Syndrome. The American Journal of Human Genetics. 90(1). 110–118. 196 indexed citations
11.
Li, Yvonne Y., Jianghong An, & Steven J.M. Jones. (2011). A Computational Approach to Finding Novel Targets for Existing Drugs. PLoS Computational Biology. 7(9). e1002139–e1002139. 93 indexed citations
12.
An, Jianghong, Anna H.Y. Law, Cindy Yang, et al.. (2009). A Novel Small-Molecule Inhibitor of the Avian Influenza H5N1 Virus Determined through Computational Screening against the Neuraminidase. Journal of Medicinal Chemistry. 52(9). 2667–2672. 54 indexed citations
13.
Chen, Zhengtang, et al.. (2008). Down‐regulation of layilin, a novel hyaluronan receptor, via RNA interference, inhibits invasion and lymphatic metastasis of human lung A549 cells. Biotechnology and Applied Biochemistry. 50(2). 89–96. 19 indexed citations
14.
Ding, Jinyong, Rongkai Xie, Jianghong An, et al.. (2008). MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochemical and Biophysical Research Communications. 377(2). 668–673. 60 indexed citations
15.
Li, Yvonne Y., Jianghong An, & Steven J.M. Jones. (2006). A large-scale computational approach to drug repositioning.. PubMed. 17(2). 239–47. 19 indexed citations
16.
An, Jianghong, Maxim Totrov, & Ruben Abagyan. (2005). Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes. Molecular & Cellular Proteomics. 4(6). 752–761. 315 indexed citations
17.
An, Jianghong, Maxim Totrov, & Ruben Abagyan. (2004). Comprehensive identification of "druggable" protein ligand binding sites.. PubMed. 15(2). 31–41. 74 indexed citations
18.
Sarai, Akinori, M. Michael Gromiha, Jianghong An, et al.. (2001). Thermodynamic databases for proteins and protein-nucleic acid interactions. Biopolymers. 61(2). 121–126. 18 indexed citations
19.
Prabakaran, Ponraj, Jianghong An, M. Michael Gromiha, et al.. (2001). Thermodynamic database for protein–nucleic acid interactions (ProNIT). Bioinformatics. 17(11). 1027–1034. 56 indexed citations
20.
An, Jianghong & Yuzuru Fujiwara. (1996). Similarity of Compounds and Reactions Based on Self Organized Conceptual Structures of Organic Synthesis Information. 6(1). 21–35.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Agostino Breakdown of academic impact, for papers by Christopher A. Pargellis Breakdown of academic impact, for papers by Roberta Bosotti Breakdown of academic impact, for papers by Brian B. Haines Breakdown of academic impact, for papers by E. Salah Breakdown of academic impact, for papers by Anna Rodina Breakdown of academic impact, for papers by Till Maurer Breakdown of academic impact, for papers by Kush Dalal Breakdown of academic impact, for papers by Ambuj Kumar Breakdown of academic impact, for papers by Wang‐Qing Liu
Rankless by CCL
2026